Also, Malakar et al. demonstrated that MALAT1 enhances HCC progression by inducing serine/arginine-rich splicing factor 1 (SRSF1) upregulation and mammalian target of rapamycin (mTOR) activation [18]. Here, MTOR is linked to hepatocellular carcinoma.